Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 499
6
Diseases
8
Unique genes
0.304
Avg. similarity score
East syndrome
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
East syndrome
Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance
Sesame syndrome
Enlarged vestibular aqueduct
Seizures, tonic-clonic, photosensitive
Littles disease
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| East syndrome | 5 | 5 | 1 |
| Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance | 5 | 5 | 1 |
| Sesame syndrome | 5 | 5 | 1 |
| Enlarged vestibular aqueduct | 4 | 4 | 3 |
| Seizures, tonic-clonic, photosensitive | 4 | 4 | 2 |
| Littles disease | 3 | 3 | 5 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| KCNJ10 | 6 / 6 | East syndrome, Enlarged vestibular aqueduct, Littles disease, Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance and 2 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Defective SLC26A4 causes Pendred syndrome (PDS) | Reactome | 1 / 1 | 1,501× | 6.66e-4 | 8.31e-3 ✓ sig. |
| Selenocysteine synthesis | Reactome | 1 / 3 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Potassium transport channels | Reactome | 1 / 3 | 500× | 2.00e-3 | 1.90e-2 ✓ sig. |
| Multifunctional anion exchangers | Reactome | 1 / 9 | 167× | 5.98e-3 | 4.10e-2 ✓ sig. |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | Reactome | 1 / 12 | 125× | 7.97e-3 | 4.94e-2 ✓ sig. |
| GABA synthesis, release, reuptake and degradation | Reactome | 1 / 13 | 115× | 8.63e-3 | 5.19e-2 |
| TRAF3-dependent IRF activation pathway | Reactome | 1 / 14 | 107× | 9.29e-3 | 5.43e-2 |
| Selenocompound metabolism | KEGG | 1 / 17 | 88.3× | 1.13e-2 | 6.12e-2 |
| Acetylcholine Neurotransmitter Release Cycle | Reactome | 1 / 17 | 88.3× | 1.13e-2 | 6.12e-2 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | Reactome | 1 / 17 | 88.3× | 1.13e-2 | 6.12e-2 |
| Serotonin Neurotransmitter Release Cycle | Reactome | 1 / 18 | 83.4× | 1.19e-2 | 6.32e-2 |
| Norepinephrine Neurotransmitter Release Cycle | Reactome | 1 / 18 | 83.4× | 1.19e-2 | 6.32e-2 |
| Dopamine Neurotransmitter Release Cycle | Reactome | 1 / 23 | 65.3× | 1.52e-2 | 7.32e-2 |
| Glutamate Neurotransmitter Release Cycle | Reactome | 1 / 24 | 62.6× | 1.59e-2 | 7.50e-2 |
| TRAF6 mediated NF-kB activation | Reactome | 1 / 24 | 62.6× | 1.59e-2 | 7.50e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| synaptic vesicle maturation | GO:0016188 | 2 / 9 | 519× | 5.76e-6 | 3.54e-4 ✓ sig. |
| conversion of seryl-tRNAsec to selenocys-tRNAsec | GO:0001717 | 1 / 1 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| positive regulation of vesicle docking | GO:0106022 | 1 / 1 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| regulation of acrosomal vesicle exocytosis | GO:2000367 | 1 / 1 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| protein localization to postsynapse | GO:0062237 | 1 / 1 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| regulation of type III interferon production | GO:0034344 | 1 / 2 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| positive regulation of glutamate secretion, neurotransmission | GO:1903296 | 1 / 2 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| glutamate reuptake | GO:0051935 | 1 / 2 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| protein targeting to Golgi apparatus | GO:0140450 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| mitotic spindle disassembly | GO:0051228 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| cytokinetic process | GO:0032506 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| axon target recognition | GO:0007412 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| regulation of regulated secretory pathway | GO:1903305 | 1 / 3 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| establishment of localization in cell | GO:0051649 | 2 / 147 | 31.8× | 1.67e-3 | 1.94e-2 ✓ sig. |
| detection of virus | GO:0009597 | 1 / 4 | 584× | 1.71e-3 | 1.96e-2 ✓ sig. |